Page 37 - Alkermes News Today

DUBLIN, May 8, 2023 /PRNewswire/ -- Alkermes plc today filed its preliminary proxy statement with the U.S. Securities and Exchange Commission in connection with its upcoming Annual General Meeting... | May 8, 2023

DUBLIN, May 8, 2023 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today filed its preliminary proxy statement with the U.S. Securities and Exchange Commission (SEC) in connection with its upcoming

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today filed its preliminary proxy statement with the U.S. Securities and Exchange Commission (SEC) in connection...

The trends of the major indices in the course of the week’s trading

NORTHAMPTON, MA / ACCESSWIRE / May 4, 2023 / Alkermes' Athlone site was recently shortlisted for gradireland's 17th annual Graduate Recruitment Awards! This award recognizes outstanding graduate intake

Datamatics Partners with Alkermes to Help Support Patients Livonia, USA, 3rd May 2023:Datamatics, a global Digital Technologies, Operations and Experiences Company, has entered... | May 3, 2023

Datamatics, has entered into a strategic partnership with Alkermes, a global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology.

Files Definitive Proxy Materials and Sends Letter to Exelixis Shareholders Encourages Shareholders to Show that the Status Quo Cannot Continue by Voting to Elect All Three of Farallon’s... | May 3, 2023

On Wednesday, 1647 stocks advanced, 1858 declined and 147 remained unchanged on the Bombay Stock Exchange (BSE), with an advance decline ratio of 0.88, indicating a positive closing of stocks in broader markets.

Boston, MA (PRWEB) May 03, 2023 -- The Melanoma Research Foundation (MRF) is thrilled to announce that WCVB Channel 5 Chronicle Reporter and Producer Nicole